6
Participants
Start Date
November 7, 2023
Primary Completion Date
February 19, 2025
Study Completion Date
February 19, 2025
Psilocybin
The IV formulation of psilocybin will be prepared using bulk psilocybin that will satisfy Good Manufacturing Practice (GMP) criteria. The IV psilocybin solution will be prepared under sterile conditions by the University of Wisconsin Pharmaceutical Research Center (PRC).
Clonidine
Clonidine will be administered orally in a 0.2mg dose
Saline
The IV placebo (saline) will be prepared under sterile conditions by the University of Wisconsin Pharmaceutical Research Center.
University of Wisconsin Hospital and Clinics, Madison
Usona Institute
OTHER
Tiny Blue Dot Foundation
OTHER
University of Wisconsin, Madison
OTHER